Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24978709

Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Int J Gynecol Cancer
Publication date
2014 Jul
First author
Grisham RN

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Grisham RN
      type
      Author
    2. name
      Iyer G
      type
      Author
    3. name
      Sala E
      type
      Author
    4. name
      Zhou Q
      type
      Author
    5. name
      Iasonos A
      type
      Author
    6. name
      DeLair D
      type
      Author
    7. name
      Hyman DM
      type
      Author
    8. name
      Aghajanian C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Grisham RN
      type
      Author
    2. name
      Iyer G
      type
      Author
    3. name
      Sala E
      type
      Author
    4. name
      Zhou Q
      type
      Author
    5. name
      Iasonos A
      type
      Author
    6. name
      DeLair D
      type
      Author
    7. name
      Hyman DM
      type
      Author
    8. name
      Aghajanian C
      type
      Author
    bibliography ids
    1. nci-bib-c4aac9fcf08e642a252d4b10
    book metadata
    content sha256
    fffbfa31944c553adac4b697649edd7681d94144ff619d153b34272f93fc08a8
    document type
    citation
    dois
    1. 10.1097/IGC.0000000000000190
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:24978709
    immutable id
    pubmed:24978709@fffbfa31944c553adac4b697649edd7681d94144ff619d153b34272f93fc08a8
    journal
    abbreviation
    Int J Gynecol Cancer
    issn electronic
    1525-1438
    issn print
    1048-891X
    issue
    6
    name
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
    nlm unique id
    9111626
    pages
    1010-4
    volume
    24
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      24978709
      provenance
      batch id
      69903be8ceab8801c81a
      provider
      NCBI PubMed ESummary
      record sha256
      0c68508fb0c095998b335b3aeb8689e645c73821e9b5bd98baffae47a5d20644
      response sha256
      1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
      retrieved at
      2026-09-09T23:47:05.208886+00:00
      publication date
      display
      2014 Jul
      precision
      month
      year
      2014
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/24978709/
      title
      Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer.

      Preserved source evidence · Not medical advice